CSS LLC’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,056
Closed -$68K 652
2022
Q4
$68K Sell
10,056
-6,010
-37% -$40.6K ﹤0.01% 545
2022
Q3
$233K Sell
16,066
-35,333
-69% -$512K 0.01% 537
2022
Q2
$506K Sell
51,399
-7,800
-13% -$76.8K 0.02% 454
2022
Q1
$873K Buy
59,199
+24,200
+69% +$357K 0.03% 381
2021
Q4
$463K Hold
34,999
0.02% 546
2021
Q3
$611K Buy
34,999
+14,500
+71% +$253K 0.03% 448
2021
Q2
$491K Sell
20,499
-19,464
-49% -$466K 0.02% 498
2021
Q1
$1.03M Buy
39,963
+32,834
+461% +$844K 0.04% 308
2020
Q4
$135K Buy
+7,129
New +$135K 0.01% 486